Sustainability Fit Arkeon offers carbon-negative, clean-label protein ingredients derived from CO2 that cover all 20 amino acids, enabling brands to lower Scope 3 emissions and strengthen sustainability narratives. Target opportunities include pilot ingredient trials with plant-based, sports nutrition, and animal feed players, plus joint marketing around decarbonization benefits.

European Scale A Vienna pilot facility and upcoming Demo Facility position Arkeon to support European customers from pilot to commercialization. Ideal targets include regional CPGs and ingredient manufacturers seeking scalable, low-carbon protein inputs; propose co-development and toll manufacturing arrangements to de-risk adoption.

Strategic Funding With investors like ICL Planet Startup Hub, Blue Horizon, and Synthesiscapital, Arkeon demonstrates credible growth trajectory and tech validation. Opportunities include co-investments, strategic partnerships, and early access to new amino-acid products and process improvements for long-term supply contracts.

Versatile Ingredients Technology enables production of all 20 proteinogenic amino acids as carbon-negative, clean-label ingredients suitable for foods, beverages, pet nutrition, and feed. Potential sales angles include supply agreements, licenses, or co-development of target amino-acid blends with flavor and functionality claims supported by regulators.

Collaborative Edge Award-winning workplace culture and a compact, agile team can accelerate joint R&D and deployment timelines. Consider opportunities for customer co-location at the Seestadt facilities, on-site demonstrations, and fast-tracked pilots to shorten the path to commercial scale.